Mark Mortenson - 04 Nov 2022 Form 4 Insider Report for Clene Inc. (CLNN)

Role: Chief Science Officer
Signature: /s/ Jerry Miraglia POA
Issuer symbol: CLNN
Transactions as of: 04 Nov 2022
Transactions value $: $0
Form type: 4
Filing time: 07 Nov 2022, 16:49:46 UTC
Previous filing: 17 Jun 2022
Next filing: 21 Feb 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CLNN	Stock Options (Right to buy)	Award	$0	+400,000		$0	400,000	04 Nov 2022	Common Stock	400,000	$1.11	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option was granted on November 4, 2022 as an option for 400,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $1.11 per share. The options vest with respect to the first 25% of such shares on November 4, 2023 and then in 36 equal installments of the balance of the shares of Common Stock on the 4th day of each calendar month thereafter beginning December 4, 2023 until such shares are fully vested.

Content

This option was granted on November 4, 2022 as an option for 400,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $1.11 per share. The options vest with respect to the first 25% of such shares on November 4, 2023 and then in 36 equal installments of the balance of the shares of Common Stock on the 4th day of each calendar month thereafter beginning December 4, 2023 until such shares are fully vested.